Top Markets
#1 Islamic Coin Islamic Coin +151.48%
#2 DOVU DOVU +48.81%
#3 Black Phoenix Black Phoenix +34.68%
#4 Velvet Velvet +30.25%
#5 Cross Cross +21.75%
#6 Akedo Akedo +18.18%
#7 DoubleZero DoubleZero +14.26%
#8 Cap Cap +11.23%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.05%
#10 HOME HOME +11.00%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Fabino Enterprises Ltd Fabino Enterprises Ltd

Fabino Enterprises Ltd

FABINO
Classement en actions #39501
Operating from its Sonipat, India base since its incorporation in 2011, Fabino... Operating from its Sonipat, India base since its incorporation in 2011, Fabino Enterprises Limited is engaged in the manufacturing, marketing, trading, and packaging of pharmaceutical and wellness-oriented consumer products throughout India. Its extensive product portfolio, marketed under the Fabino and Keepshine brands, includes allopathic and select herbal medications—such as tablets, ointments, and syrups—along with various food and general wellness items. The company also extends its reach globally by exporting wellness and Fast-Moving Consumer Goods (FMCG) like coffee, malt powder, protein powder, and hair shampoo. Fabino's products are distributed and promoted via its own robust internal network and specialized sales force. Notably, the entity adopted its current name, Fabino Enterprises Limited, in June 2024, having previously been known as Fabino Life Sciences Limited.
Prix de l'action
$0.22413867
Dernière synchronisation: 2026-05-25
Capitalisation boursière
$463.14K
Changement (1 jour)
0.00%
Changement (1 an)
-24.40%
Pays
IN
Échange Fabino Enterprises Ltd (FABINO)

Catégorie

Healthcare
Ratio P/B pour Fabino Enterprises Ltd (FABINO)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Fabino Enterprises Ltd, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Fabino Enterprises Ltd de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US